Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page Not Available ()Premium Content

2015-03-02@10:56:20 ET
Charcot-Marie-Tooth Disease Pipeline Review Therapeutics 2015 - 4 Companies & 7 Drug Profiles (MTO)

2015-03-02@09:22:00 ET
Secondary Progressive Multiple Sclerosis (SPMS) Therapeutics Pipeline Review 2015 - 11 Companies & 15 Drug Profiles (MTO)

2015-03-02@09:16:32 ET
Myotonic Dystrophy - Pipeline Review H1 2015 (MTO)

2015-02-25@23:00:59 ET
US Patent Issued to Genzyme, Biochemical Institute, Christian-Albrechts University Kiel on Feb. 24 for "Methods of producing a secreted protein" (American, German Inventors) (ABW)

2015-02-24@08:00:08 ET
Castle Biosciences Announces New Director Appointment and CFO Hire (BIZ)

2015-01-22@07:35:02 ET
ARIAD Announces Appointment of Thomas J. DesRosier, Senior Pharmaceutical-Industry Counsel, as Chief Legal and Administrative Officer (BIZ)

2015-01-19@17:31:01 ET
Muscular Dystrophy Therapeutic Pipeline Review Research H2 2014 Report Available at (PRW)

2015-01-12@11:17:42 ET
Global Orphan Drug Pipeline & Regulatory Insight 2015 (MTO)

2015-01-12@11:12:26 ET
Europe Orphan Drug Market & Clinical Trial Insight 2015 (MTO)

2014-12-18@04:24:53 ET
Malaria - Pipeline Review, H1 2014 (MTO)

2014-12-16@08:00:00 ET
Spark Therapeutics Appoints Rare Disease Pioneer Dr. Rogerio Vivaldi as Chief Commercial Officer (PRN)

2014-12-15@05:14:22 ET
Genzyme initiates treatment of first patients in multiple sclerosis study (DTM)

2014-12-03@08:38:10 ET
Fabry Disease - Pipeline Review, H2 2014 (MTO)